Why a special Asia Pacific issue on systemic lupus erythematosus? Perspectives from China

APLAR Journal of Rheumatology

Volumn 9, Issue 4, 2006, Pages 315-316

  Chen, Shun Le ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; INTERLEUKIN 10; METHOTREXATE; PREDNISONE;

ARTICLE; BODY WEIGHT DISORDER; CAUSE OF DEATH; CHINA; DRUG EFFICACY; HUMAN; INCIDENCE; LOW DRUG DOSE; LUNG INFECTION; OPPORTUNISTIC INFECTION; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REMISSION; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; WEIGHT GAIN;

EID: 33750991041     PISSN: 02190494     EISSN: 14798077     Source Type: Journal    
DOI: 10.1111/j.1479-8077.2006.00234.x     Document Type: Article

References (14)

1. Rothfield NF (1982) Current approach to SLE and its subsets. Disease-A-Month Year Book Medical Publishers Inc., Chicago.
2. Huang M, Chen S, Lu G, et al. (1985) An epidemiological survey of systemic lupus erythematosus in Shanghai. Chin J Intern Med 24, 451-4.
3. Hochberg MC, Perlmutter DL, Medsger TA, et al. (1995) The prevalence of self-reported physician -diagnosed systemic lupus erythematosus in the United States. Lupus 4, 454-6.
4. The American Collage of Rheumatology (1999) Guidelines for Referral and Management of Systemic Lupus Erythematosus in Adults. Arthritis Rheum 42, 1785-96.
5. Feng XB, Shen N, Chen SL, et.al. (2003) Susceptibility gene of systemic lupus erythematosus in 16q12 Chinese cohort. Chin J Med Genet 20, 27-30.
6. Shen N, Wu H, Chen S, et.al. (2003) Identification of a novel candidate gene PBX1 within the putative systemic erythematosus susceptibility locus at lq23-24 in a Chinese cohort. Chin J Rheumatol 7, 399-405.
7. Ye S, Pang H, Gu YY, et.al. (2003) Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1. Rheumatology (Oxford) 42, 1155-63.
8. Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY (2003) Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun 4, 177-86.
9. Chen S, Chen S, Gu Y, et al. (2000) An eighteen year cluster follow-up study of 50 SLE patients. Chinese J Rheumatol 1, 27-30.
10. Chen S, Hu D (2000) The relationship between Th1/Th2-type cells and disease activity in patients with systemic lupus erythematosus. Chinese Med J 113, 877-80.
11. Hu D, Chen S (1999) Imbalance of Th1/Th2 cytokines and its relation to disease activity in patients with systemic lupus erythematosus. Chin J Rheumatol 3, 8-11.
12. Zhang W, Chen C (2003) An overview on Systemic lupus erythematosus pregnancy. Mod Rheumatol 13, 293-300.
13. Vasoo S, Hughes GRV (2005) Theory, targets and therapy in systemic lupus erythematosus. Lupus 14, 181-8.
14. Li T, Chen S, Bao C, Li L, Chen S (2002) Use of prednisone, methotrexate and chloroquine to treat systemic lupus erythromatosus. Chinese J Rheumatol 6, 417-9.